Additional evidence to support routine cytomegalovirus prophylaxis for all D+/R+ renal graft recipients
- PMID: 22406751
- DOI: 10.1097/TP.0b013e318247a7d4
Additional evidence to support routine cytomegalovirus prophylaxis for all D+/R+ renal graft recipients
Comment on
-
Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.Transplantation. 2012 Jan 15;93(1):61-8. doi: 10.1097/TP.0b013e318238dab3. Transplantation. 2012. PMID: 22094954 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
